CRISPR Therapeutics
CRSP
#3196
Rank
HK$27.99 B
Marketcap
HK$326.39
Share price
-3.45%
Change (1 day)
-44.21%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -HK$41.54

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$41.20. In 2022 the company made an earnings per share (EPS) of -HK$65.06 a decrease over its 2021 EPS that were of HK$38.79.

EPS history for CRISPR Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$41.54-36.15%
2022-HK$65.06-267.74%
2021HK$38.79-194.33%
2020-HK$41.12-576.58%
2019HK$8.63-132.36%
2018-HK$26.66100.58%
2017-HK$13.29159.42%
2016-HK$5.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.95-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA